←
Dr. Gabriel Pardo417 posts
Dr. Gabriel Pardo avatar

Dr. Gabriel Pardo

@DocforMS

Director of the OMRF Multiple Sclerosis Center of Excellence, where MS is approached with optimal clinical care and scientific innovation. Opinions are my own.

◷ Joined March 2011▧ 20 Photos and videos
Dr. Gabriel Pardo avatar
Dr. Gabriel Pardo@DocforMS·May 6

Innovative ways to assess disease status and progression in #MS is an unmet need. Proud of our team's work using eye movement analysis as a way to assess cognition and correlate with functional and anatomical metrics @OMRF journals.sagepub.com/doi/10.…

Joe Sabatino avatar
⟳ Dr. Gabriel Pardo retweeted
Joe Sabatino@jsabatino37·Jan 13

EBV is required for the development of multiple sclerosis, but it’s not known how a common virus leads to disease. 3 exciting new papers in @CellCellPress provide major insights into how this may occur:

Dr. Gabriel Pardo avatar
Dr. Gabriel Pardo@DocforMS·3 Feb 2025

Happy to share this collaborative work looking at long term results of a high efficacy DMT in early #MS #ocrelizumab ⁦@OMRF⁩ ⁦⁦@AaronBosterMD⁩ ⁦@drbarrysinger⁩ ⁦@Brandon_Beaber⁩ ⁦@MSViewsandNews⁩ neurology.org/doi/10.1212/WN…

Darin T. Okuda, M.D., M.Sc., F.A.A.N., F.A.N.A. avatar
⟳ Dr. Gabriel Pardo retweeted
Darin T. Okuda, M.D., M.Sc., F.A.A.N., F.A.N.A.@okudaMD·21 Aug 2024

Have you ever wondered about the magnitude of new/unused disease modifying therapies for multiple sclerosis that may be out there? Retail costs for these specialty medicines are near $100K per year! This is a before and after photo from 2020. Imagine for a minute what we have collected up to present day. Enthusiasm for fixing the problem is low especially when compensation has already occurred along the distribution chain. @davidbalat @patientsrising @ectrims @actrims @mssociety @docforms @DrugChannels @elonmusk

Post attachment